Transformation of ginsenosides from notoginseng by artificial gastric juice can increase cytotoxicity toward cancer cells

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 12, 2014, Pages 2558-2573

  Wang, Jing Rong ^a,b   Yau, Lee Fong ^a   Zhang, Rui ^b,c   Xia, Yun ^b   Ma, Jing ^b   Ho, Hing Man ^b   Hu, Ping ^c   Hu, Ming ^d   Liu, Liang ^a,b   Jiang, Zhi Hong ^a,b  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

gastric juice; ginsenoside; LC MS; notoginseng; transformation

Indexed keywords

BIOMOLECULES; BODY FLUIDS; CELLS; DEHYDRATION; HYDRATION; METABOLISM; METABOLITES; DISEASES;

GASTRIC JUICE; GINSENOSIDES; LC-MS; NOTOGINSENG; TRANSFORMATION;

PHARMACODYNAMICS;

GINSENOSIDE; PLANT EXTRACT;

ARTICLE; BIOLOGICAL MODEL; BIOTRANSFORMATION; CHEMICAL STRUCTURE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; METABOLISM; PANAX NOTOGINSENG; STOMACH; STOMACH JUICE; TUMOR CELL LINE;

BIOTRANSFORMATION; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GASTRIC JUICE; GINSENOSIDES; HUMANS; MASS SPECTROMETRY; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PANAX NOTOGINSENG; PLANT EXTRACTS; STOMACH;

EID: 84896963345     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf405482s     Document Type: Article

References (66)

1. Ng, T. B. Pharmacological activity of sanchi ginseng (Panax notoginseng) J. Pharm. Pharmacol. 2006, 58 (8) 1007-1019
2. Konoshima, T.; Takasaki, M.; Tokuda, H. Anti-carcinogenic activity of the roots of Panax notoginseng. II Biol. Pharm. Bull. 1999, 22 (10) 1150-1152
3. Wang, C. Z.; Yuan, C. S. Potential role of ginseng in the treatment of colorectal cancer Am. J. Chin. Med. 2008, 36 (6) 1019-1028
4. Yang, J. M.; Lu, F. H.; Jin, S. K.; Sun, S. W.; Zhao, Y. X.; Wang, S. J.; Zhou, X. H. A cohort study on the predictive value of factors influencing cardio-cerebro vascular death among people over 40 years of age Zhonghua Liuxingbingxue Zazhi 2007, 28 (2) 119-122
5. Ruan, J. Q.; Leong, W. I.; Yan, R.; Wang, Y. T. Characterization of metabolism and in vitro permeability study of notoginsenoside R1 from Radix notoginseng J. Agric. Food Chem. 2010, 58 (9) 5770-5776
6. He, N. W.; Zhao, Y.; Guo, L.; Shang, J.; Yang, X. B. Antioxidant, antiproliferative, and pro-apoptotic activities of a saponin extract derived from the roots of Panax notoginseng (Burk.) F.H. Chen J. Med. Food 2012, 15 (4) 350-359
7. Yoshikawa, M.; Murakami, T.; Ueno, T.; Hirokawa, N.; Yashiro, K.; Murakami, N.; Yamahara, J.; Matsuda, H.; Saijoh, R.; Tanaka, O. Bioactive saponins and glycosides. IX. Notoginseng (2): structures of five new dammarane-type triterpene oligoglycosides, notoginsenosides-E, -G, -H, -I, and -J, and a novel acetylenic fatty acid glycoside, notoginsenic acid β-sophoroside, from the dried root of Panax notoginseng (Burk.) F. H. Chen Chem. Pharm. Bull. 1997, 45, 1056-1062
8. Wang, X.-Y.; Wang, D.; Ma, X.-X.; Zhang, Y.-J.; Yang, C.-R. Two new dammarane-type bisdesmosides from the fruit pedicels of Panax notoginseng Helv. Chim. Acta 2008, 91, 60-66
9. Christensen, L. P. Ginsenosides: chemistry, biosynthesis, analysis, and potential health effects Adv. Food Nutr. Res. 2009, 55, 1-99
10. Wan, J. B.; Li, S. P.; Chen, J. M.; Wang, Y. T. Chemical characteristics of three medicinal plants of the Panax genus determined by HPLC-ELSD J. Sep. Sci. 2007, 30 (6) 825-832
11. Wang, J. R.; Leung, C. Y.; Ho, H. M.; Chai, S.; Yau, L. F.; Zhao, Z. Z.; Jiang, Z. H. Quantitative comparison of ginsenosides and polyacetylenes in wild and cultivated American ginseng Chem. Biodiversity 2010, 7 (4) 975-983
12. Karikura, M.; Miyase, T.; Tanizawa, H.; Taniyama, T.; Takino, Y. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VI. The decomposition products of ginsenoside Rb2 in the stomach of rats Chem. Pharm. Bull. (Tokyo) 1991, 39 (2) 400-404
13. Karikura, M.; Miyase, T.; Tanizawa, H.; Taniyama, T.; Takino, Y. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats Chem. Pharm. Bull. (Tokyo) 1991, 39 (9) 2357-2361
14. Odani, T.; Tanizawa, H.; Takino, Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. IV. Decomposition of ginsenoside-Rg1 and -Rb1 in the digestive tract of rats Chem. Pharm. Bull. (Tokyo) 1983, 31 (10) 3691-3697
15. Wang, Y.; Wang, B. X.; Liu, T. H.; Minami, M.; Nagata, T.; Ikejima, T. Metabolism of ginsenoside Rg1 by intestinal bacteria. II. Immunological activity of ginsenoside Rg1 and Rh1 Acta Pharmacol. Sin. 2000, 21, 792-796
16. Bae, E.-A.; Han, M. J.; Kim, E.-J.; Kim, D.-H. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants Arch. Pharm. Res. 2004, 27, 61-67
17. Bae, E.-A.; Choo, M.-K.; Park, E.-K.; Park, S.-Y.; Shin, H.-Y.; Kim, D.-H. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity Biol. Pharm. Bull. 2002, 25, 743-747
18. Bae, E.-A.; Shin, J.-E.; Kim, D.-H. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect Biol. Pharm. Bull. 2005, 28, 1903-1908
19. Hasegawa, H.; Lee, K. S.; Nagaoka, T.; Tezuka, Y.; Uchiyama, M.; Kadota, S.; Saiki, I. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters Biol. Pharm. Bull. 2000, 23, 298-304
20. Akao, T.; Kida, H.; Kanaoka, M.; Hattori, M.; Kobashi, K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng J. Pharm. Pharmacol. 1998, 50, 1155
21. Hasegawa, H.; Sung, J. H.; Benno, Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins Planta Med. 1997, 63, 436-440
22. Takino, Y. Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats Yakugaku Zasshi 1994, 114, 550-564
23. Hasegawa, H. Proof of the mysterious efficacy of ginseng. Basic and clinical trials: Metabolic activation of ginsenoside: Deglycosylation by intestinal bacteria and esterification with fatty acid J. Pharmacol. Sci. (Tokyo) 2004, 95, 153-157
24. Joo, K. M.; Lee, J. H.; Jeon, H. Y.; Park, C. W.; Hong, D. K.; Jeong, H. J.; Lee, S. J.; Lee, S. Y.; Lim, K. M. Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method J. Pharm. Biomed. Anal. 2010, 51 (1) 278-283
25. Xie, H. T.; Wang, G. J.; Lv, H.; Sun, R. W.; Jiang, X. L.; Li, H.; Wang, W.; Huang, C. R.; Xu, M. J. Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs Eur. J. Drug Metab. Pharmacokinet. 2005, 30 (1-2) 63-67
26. Xie, H. T.; Wang, G. J.; Sun, J. G.; Tucker, I.; Zhao, X. C.; Xie, Y. Y.; Li, H.; Jiang, X. L.; Wang, R.; Xu, M. J.; Wang, W. High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies J Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2005, 818 (2) 167-173
27. Dong, H.; Bai, L. P.; Wong, V. K.; Zhou, H.; Wang, J. R.; Liu, Y.; Jiang, Z. H.; Liu, L. The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives Molecules (Basel, Switzerland) 2011, 16 (12) 10619-10630
28. Wakabayashi, C.; Hasegawa, H.; Murata, J.; Saiki, I. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration Oncol. Res. 1997, 9 (8) 411-417
29. Kaneko, H.; Nakanishi, K. Proof of the mysterious efficacy of ginseng. Basic and clinical trials: clinical effects of medical ginseng, korean red ginseng: specifically, its anti-stress action for prevention of disease J. Pharmacol. Sci. 2004, 95 (2) 158-162
30. Zhang, Z.; Du, G. J.; Wang, C. Z.; Wen, X. D.; Calway, T.; Li, Z.; He, T. C.; Du, W.; Bissonnette, M.; Musch, M. W.; Chang, E. B.; Yuan, C. S. Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 Interactions Int. J. Mol. Sci. 2013, 14 (2) 2980-2995
31. Hu, C.; Song, G.; Zhang, B.; Liu, Z.; Chen, R.; Zhang, H.; Hu, T. Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway J. Cell. Mol. Med. 2012, 16 (1) 96-106
32. Yang, Z.; Wang, J. R.; Niu, T.; Gao, S.; Yin, T.; You, M.; Jiang, Z. H.; Hu, M. Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora Drug Metab. Dispos. 2012, 40 (8) 1538-1544
33. Tawab, M. A.; Bahr, U.; Karas, M.; Wurglics, M.; Schubert-Zsilavecz, M. Degradation of ginsenosides in humans after oral administration Drug Metab. Dispos. 2003, 31 (8) 1065-1071
34. Hu, Z.; Yang, J.; Cheng, C.; Huang, Y.; Du, F.; Wang, F.; Niu, W.; Xu, F.; Jiang, R.; Gao, X.; Li, C. Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi) Drug Metab. Dispos. 2013, 41 (7) 1457-1469
35. Qian, T.; Jiang, Z. H.; Cai, Z. High-performance liquid chromatography coupled with tandem mass spectrometry applied for metabolic study of ginsenoside Rb1 on rat Anal. Biochem. 2006, 352 (1) 87-96
36. Liu, H.; Yang, J.; Du, F.; Gao, X.; Ma, X.; Huang, Y.; Xu, F.; Niu, W.; Wang, F.; Mao, Y.; Sun, Y.; Lu, T.; Liu, C.; Zhang, B.; Li, C. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats Drug Metab. Dispos. 2009, 37 (12) 2290-2298
37. Yang, Z.; Wang, J. R.; Niu, T.; Gao, S.; Yin, T.; You, M.; Jiang, Z. H.; Hu, M. Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora Drug Metabolism and Dispos. 2012, 40 (8) 1538-1544
38. Zhou, H.; Hou, S. Z.; Luo, P.; Zeng, B.; Wang, J. R.; Wong, Y. F.; Jiang, Z. H.; Liu, L. Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism J. Ethnopharmacol. 2011, 135 (2) 287-298
39. Teng, R.-W.; Li, H.-Z.; Wang, D.-Z.; Yang, C.-R. Hydrolytic Reaction of Plant Extracts to Generate Molecular Diversity: New Dammarane Glycosides from the Mild Acid Hydrolysate of Root Saponins of Panax notoginseng Helv. Chim. Acta 2004, 87 (5) 1270-1278
40. Jiang, Z.-H.; Fukuoka, R.; Aoki, F.; Tanaka, T.; Kouno, I. Dammarane-type triterpene glycosides from the leaves of Rhoiptelea chiliantha Chem. Pharm. Bull. 1999, 47, 257-262
41. Tu, Y.; Wang, Z.-X.; Shi, Y. An Efficient Asymmetric Epoxidation Method for trans -Olefins Mediated by a Fructose-Derived Ketone J. Am. Chem. Soc. 1996, 118, 9806-9807
42. Teng, R.-W.; Li, H.-Z.; Wang, D.-Z.; Yang, C.-R. Hydrolytic reaction of plant extracts to generate molecular diversity: new dammarane glycosides from the mild acid hydrolysate of root saponins of Panax notoginseng Helv. Chim. Acta 2004, 87, 1270-1278
43. Ko, S. R.; Suzuki, Y.; Kim, Y. H.; Choi, K. J. Enzymatic synthesis of two ginsenoside Re-beta-xylosides Biosci. Biotechnol. Biochem. 2001, 65 (5) 1223-1226
44. Ko, S. R.; Choi, K. J.; Suzuki, K.; Suzuki, Y. Enzymatic preparation of ginsenosides Rg2, Rh1, and F1 Chem. Pharm. Bull. (Tokyo) 2003, 51 (4) 404-408
45. Kasai, R.; Hara, K.; Dokan, R.; Suzuki, N.; Mizutare, T.; Yoshihara, S.; Yamasaki, K. Major metabolites of ginseng sapogenins formed by rat liver microsomes Chem. Pharm. Bull. (Tokyo) 2000, 48 (8) 1226-127
46. Duc, N. M.; Kasai, R.; Ohtani, K.; Ito, A.; Nham, N. T.; Yamasaki, K.; Tanaka, O. Saponins from Vietnamese ginseng, Panax vietnamensis Ha et Grushv. collected in central Vietnam. III Chem. Pharm. Bull. (Tokyo) 1994, 42 (3) 634-640
47. Wang, J. R.; Yamasaki, Y.; Tanaka, T.; Kouno, I.; Jiang, Z. H. Dammarane-type triterpene saponins from the flowers of Panax notoginseng Molecules 2009, 14 (6) 2087-2094
48. Yoshikawa, M.; Murakami, T.; Ueno, T.; Yashiro, K.; Hirokawa, N.; Murakami, N.; Yamahara, J.; Matsuda, H.; Saijoh, R.; Tanaka, O. Bioactive saponins and glycosides. VIII. Notoginseng (1): new dammarane-type triterpene oligoglycosides, notoginsenosides-A, -B, -C, and -D, from the dried root of Panax notoginseng (Burk.) F.H. Chen Chem. Pharm. Bull. (Tokyo) 1997, 45 (6) 1039-1045
49. Cheng, C. C.; Yang, S. M.; Huang, C. Y.; Chen, J. C.; Chang, W. M.; Hsu, S. L. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells Cancer Chemother. Pharmacol. 2005, 55 (6) 531-540
50. Popovich, D. G.; Kitts, D. D. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells J. Biochem. Mol. Toxicol. 2004, 18 (3) 143-149
51. Popovich, D. G.; Kitts, D. D. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2 Can. J. Physiol. Pharmacol. 2004, 82 (3) 183-190
52. Hasegawa, H.; Sung, J. H.; Benno, Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins Planta Med. 1997, 63 (5) 436-440
53. Akao, T.; Kida, H.; Kanaoka, M.; Hattori, M.; Kobashi, K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng J. Pharm. Pharmacol. 1998, 50 (10) 1155-1160
54. Gu, Y.; Wang, G. J.; Sun, J. G.; Jia, Y. W.; Wang, W.; Xu, M. J.; Lv, T.; Zheng, Y. T.; Sai, Y. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs Food Chem. Toxicol. 2009, 47 (9) 2257-2268
55. Xie, H. T.; Wang, G. J.; Lv, H.; Sun, R. W.; Jiang, X. L.; Li, H.; Wang, W.; Huang, C. R.; Xu, M. J. Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs Eur. J. Drug Metab. Pharmacokinet. 2005, 30 (1-2) 63-67
56. Zhao, J.; Su, C.; Yang, C.; Liu, M.; Tang, L.; Su, W.; Liu, Z. Determination of ginsenosides Rb1, Rb2, and Rb3 in rat plasma by a rapid and sensitive liquid chromatography tandem mass spectrometry method: application in a pharmacokinetic study J. Pharm. Biomed. Anal. 2012, 64-65, 94-97
57. Liu, H.; Yang, J.; Du, F.; Gao, X.; Ma, X.; Huang, Y.; Xu, F.; Niu, W.; Wang, F.; Mao, Y.; Sun, Y.; Lu, T.; Liu, C.; Zhang, B.; Li, C. Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats Drug Metab. Dispos. 2009, 37 (12) 2290-2298
58. Yang, Z.; Gao, S.; Wang, J.; Yin, T.; Teng, Y.; Wu, B.; You, M.; Jiang, Z.; Hu, M. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms Drug Metab. Dispos. 2011, 39 (10) 1866-1872
59. Gu, Y.; Wang, G. J.; Wu, X. L.; Zheng, Y. T.; Zhang, J. W.; Ai, H.; Sun, J. G.; Jia, Y. W. Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters Xenobiotica 2010, 40 (9) 602-612
60. Zhang, J.; Zhou, F.; Niu, F.; Lu, M.; Wu, X.; Sun, J.; Wang, G. Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics PloS One 2012, 7 (4) e35768
61. Hao, H.; Lai, L.; Zheng, C.; Wang, Q.; Yu, G.; Zhou, X.; Wu, L.; Gong, P.; Wang, G. Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship Drug Metab. Dispos. 2010, 38 (10) 1731-1739
62. Liu, Y.; Ma, H.; Zhang, J. W.; Deng, M. C.; Yang, L. Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes Planta Med. 2006, 72 (2) 126-131
63. Chang, T. K.; Chen, J.; Benetton, S. A. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1 Drug Metab. Dispos. 2002, 30 (4) 378-384
64. Nag, S. A.; Qin, J. J.; Wang, W.; Wang, M. H.; Wang, H.; Zhang, R. Ginsenosides as Anticancer Agents: In Vitro and in Vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action Front. Pharmacol. 2012, 3, 25
65. Wong, V. K.; Cheung, S. S.; Li, T.; Jiang, Z. H.; Wang, J. R.; Dong, H.; Yi, X. Q.; Zhou, H.; Liu, L. Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK-p53 and NF-kappaB signaling J. Cell. Biochem. 2010, 111 (4) 899-910
66. Nguyen, M. D.; Kasai, R.; Ohtani, K.; Ito, A.; Nguyen, T. N.; Yamasaki, K.; Tanaka, O. Saponins from Vietnamese Ginseng, Panax vietnamensis HA et Grushv. Collected in central Vietnam. II Chem. Pharm. Bull. (Tokyo) 1994, 42 (1) 115-122